Briefs: Krsnaa Diagnostics and Anuh Pharma
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Subscribe To Our Newsletter & Stay Updated